Position in NVS
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$470,160
+$11,910 QoQ
Shares Held
3,000
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#916
of 1,603 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ABNER HERRMAN & BROCK LLC holds $83,857,322 across 8 Drug Manufacturers - General names. NVS ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,138 | $32,550,134 | |
| 2 | MRK |
Merck & Co., Inc.
|
202,424 | $26,011,484 | |
| 3 | JNJ |
Johnson & Johnson
|
79,588 | $20,212,964 | |
| 4 | AMGN |
Amgen Inc
|
8,418 | $3,048,326 | |
| 5 | ABBV |
AbbVie Inc.
|
2,515 | $632,874 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
10,000 | $576,200 | |
| 7 | NVS |
Novartis AG
This page
|
3,000 | $470,160 | |
| 8 | PFE |
Pfizer Inc
|
14,750 | $355,180 |
All Filings in NVS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $470,160 | 3,000 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $458,250 | 3,000 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $413,610 | 3,000 | Shares | Sole | 2026-01-06 | |
| 2025-09-30 | $384,720 | 3,000 | Shares | Sole | 2025-10-14 | |
| No filing history on record for this holder in this stock. | ||||||